Transcript Document

IKMG - International Kidney and Monoclonal Gammopathy
Research Group
2nd International Meeting
La Rochelle, France, September 3-4, 2015
http://internationalkidneymonoclonalgammopathy.org
Dear Friends and Colleagues,
We would like to invite you to attend the second international IKMG meeting in La Rochelle which is
taking place in September 2015. The goal of the IKMG is to promote research into, and understanding
of, kidney diseases resulting from monoclonal gammopathies and we are very excited about the
program our organizing committee has put together. We plan to include state of the art lectures on
the pathology, diagnostics and treatment of monoclonal gammopathy-related kidney diseases
presented by experts from around the world. A poster and plenary session will cover the latest
advances in this evolving field. This meeting will hopefully stimulate exchanges between clinicians
and researchers, and open up new perspectives for diagnostic and therapeutic approaches to the
treatment of these rare disorders, through a better understanding of their pathophysiological
mechanisms. Call for abstracts will be announced in May.
La Rochelle is a very pleasant city located on the west coast of France. The meeting will be held at the
Espace Encan, close to the old port in the historical city center, with a wide choice of hotels within
walking distance. The social program will be a unique opportunity to discover the best local food.
We look forward to meeting you in La Rochelle,
GENERAL
Guy Touchard, Congress
PresidentINFORMATION
Nelson Leung, IKMG President
address:
ace Encan, Quai Louis Prunier, BP 3106, 17033 La Rochelle,
Online Registration and Hotel Reservation:
http://reservation.larochelle-evenements.fr/event/registration?eventid=73&langue=UK
Contact: Tiffany Barbier, La Rochelle Evenements,
Quai Louis Prunier – BP 3106 17033 La Rochelle cedex 01, France
Tel : (33) 5 46 45 91 43. E-mail: www.larochelle-evenements.fr
Registration fees (including lunch and dinner on Thursday September 3rd):
Seniors: 325 Euros
MD or PhD age less than 35 years: 175 Euros
Trainees, PhD students: 75 Euros
The number of participants will be limited to 250, registration will close on Wednesday August 26, 2015
PRELIMINARY PROGRAM
Thursday, Sept. 3. Monoclonal gammopathy of renal significance - MGRS
8:00 a.m. – 9:15 a.m. Introduction: Guy Touchard and Nelson Leung
- The history of monoclonal gammopathies: Robert A. Kyle (Mayo Clinic, Rochester, MN, USA)
- MGRS: an evolving concept: Nelson Leung (Mayo Clinic, Rochester, MN, USA)
- Classification of renal disorders in monoclonal gammopathies: Guy Touchard (University of Poitiers, France)
- The kidney biopsy in MGRS: recent advances in pathology: Samih Nasr (Mayo Clinic, Rochester, MN, USA)
- Coffee break
9:30 a.m. – 12:30 a.m. Proximal Tubule in Monoclonal Gammopathy: From the microscope to the Lab
- Light chain (LC) tubulopathy with crystals: Vivette D’Agati (Columbia University, New-York, NY, USA)
- LC proximal tubulopathy without crystals: Guillermo A. Herrera (Louisiana State University, Shreveport, LA, USA)
- LC-induced interstitial nephritis: Maria M. Picken (Loyola University Medical Center, Chicago, IL, USA)
- Inflammatory pathways involved in proximal tubular injury: Veichi Batuman (Tulane University, New Orleans, LA, USA)
- Panel discussion
2:00 p.m. – 3:00 p.m. Update on monoclonal protein detection/measurement
- New free light chain assays: Ashu Wechalekar (National Amyloidosis Centre, London, UK)
- Mass spectrometry: David Murray (Mayo Clinic, Rochester, MN, USA)
3:00 p.m. – 4:15 p.m. New Renal response and emerging therapies in AL amyloidosis
- Assessing renal response in AL amyloidosis: Giampaolo Merlini (University of Pavia, Italy)
- Anti-SAP therapy: Julian Gillmore (National Amyloidosis Centre, London, UK)
- Anti-fibril therapy: Brendan Weiss (University of Pennsylvania, Philadelphia, PA, USA)
- Coffee break
4:30 p.m. – 6:00 p.m. Update on the management of myeloma cast nephropathy
- Chemotherapeutic options: Efstathios Kastritis (University of Athens, Athens, Greece)
- Free light chain removal: Colin Hutchison (Hawke's Bay DHB, New Zealand)
- Response measurement: Heinz Ludwig (Wilhelmine Hospital, Vienna, Austria)
- Group discussion
6:00 p.m. Poster viewing and wine reception, dinner to follow
Friday, Sept. 4
8:30 a.m. – 10:30 a.m. Update in pathophysiology: animal models
- Cast nephropathy: Paul Sanders (University of Birmingham Alabama, Birmingham, AL, USA)
- LC Fanconi syndrome: mouse and cellular studies: Olivier Devuyst (University of Zurich, Switzerland)
- AL amyloidosis: Guillermo A. Herrera (Louisiana State University, Shreveport, LA, USA)
- Randall-type MIDD: Christophe Sirac (University of Limoges, France)
- Coffee break
10:45 a.m. – 12:00 a.m. C3 glomerulopathy and monoclonal gammopathy
- C3 GP and monoclonal gammopathy: the disease spectrum: Frank Bridoux (University of Poitiers, France)
- The complement system in C3GP and monoclonal gammopathy: Véronique Frémeaux-Bacchi (HEGP, Paris, France)
12:00 – 12:45: Extra-renal manifestations of monoclonal gammopathy: Jean Paul Fermand (Saint Louis University
Hospital, Paris, France)
2:00 p.m. – 4:00 p.m. Oral communications
4:00 p.m. Closing remarks
4:30 p.m. – 5:30 p.m. IKMG board meeting
Sponsors: